Divi's Laboratories News, Corporate filings and Earnings/Conference Calls

Name: Latest research reports of Divi's Laboratories Ltd. authored by Deven Choksey and published by - Trendlyne research reports.
Item: Divi's Laboratories Ltd.
Rating: 3
Author: Deven Choksey

Keep track of all breaking news and updates on Divi's Laboratories from all sources in a single place.

Divi's Laboratories Ltd.

30 Sep 2026

9196.00

-0.57%

SAST

Divis Laboratories Ltd - 532488 - Closure of Trading Window

BSE India

Intimation of closure of Trading Window from 01.10.2026 till 48 hours of declaration of financial results for the quarter and half year ended 30.09.2026.

pdf

Divi's Laboratories Ltd.

12 Sep 2026

9196.00

-0.57%

Company Update

Divis Laboratories Ltd - 532488 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Newspaper Clippings - Special Window for transfer and dematerialisation of physical shares

pdf

Divi's Laboratories Ltd.

10 Aug 2026

9196.00

-0.57%

AGM

Divis Laboratories Ltd - 532488 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

BSE India

Submission of Scrutinizer''s report on 36th AGM resolutions.

pdf

Divi's Laboratories Ltd.

10 Aug 2026

9196.00

-0.57%

AGM

Divis Laboratories Ltd - 532488 - Shareholder Meeting / Postal Ballot-Outcome of AGM

BSE India

Outcome of 36th AGM - submission of AGM proceedings, voting results and Scrutinizer''s report.

pdf

Divi's Laboratories Ltd.

06 Aug 2026

9196.00

-0.57%

Earnings Call

Divis Laboratories Ltd - 532488 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Submission of transcript of Earnings Conference Call held on August 01, 2026

pdf

Divi's Laboratories Ltd.

04 Aug 2026, 12:00AM

9196.00

-0.57%

Outlook

Hold: Divi's Laboratories Ltd.

Target

Deven Choksey

Divi's Laboratories' outlook remains positive, supported by a healthy pipeline of custom synthesis projects, continued expansion in peptides, and the gradual commercialization of contrast media products.

Divi's Laboratories Ltd. is trading above its 200 day SMA of 7051.5

Divi's Laboratories Ltd.

03 Aug 2026

9196.00

-0.57%

Company Update

Divis Laboratories Ltd - 532488 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Newspaper clippings regarding unaudited financial results of the Company for the quarter ended June 30, 2026

pdf

Divi's Laboratories Ltd.

02 Aug 2026

9196.00

-0.57%

CDMO execution drives earnings beat

Neutral: Divi's Laboratories Ltd.

Target

Motilal Oswal

Divi’s Lab (DIVI) delivered higher-than-estimated financial performance for 1QFY27, with a 12%/40%/37% beat on revenue/EBITDA/PAT. Strong traction in the custom synthesis business led to an earnings surprise for the quarter.